AnRes Clinical ApS: Financial statements 2025
CVR: 41147504
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AnRes Clinical ApS (CVR 41147504) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,457,177 and a net result of DKK 286,285 compared with DKK 1,120,314 the year before. That is a decrease of 40.4% compared with the year before. Equity in the 2025 report amounted to DKK 2,306,048. The solvency ratio was 74.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,457,177
- Profit/Loss
- DKK 286,285
- Equity
- DKK 2,306,048
- Total Assets
- DKK 3,081,984
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.5M | 286K | 2.3M | 2 |
| 2024 | - | 2.4M | 1.1M | 2.1M | 2 |
| 2023 | - | 1.1M | 117K | 1.1M | 2 |
| 2022 | - | 1.4M | 102K | 973K | 3 |
| 2021 | - | 1.2M | 394K | 871K | 2 |
Official annual report
How creditworthy is AnRes Clinical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AnRes Clinical ApS has published its annual report for 2024. Gross profit came to DKK 2,445,527, and the net result was DKK 1,120,314.
About AnRes Clinical ApS
AnRes Clinical ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Anna Katarzyna Polak. The company is owned by Anna Katarzyna Polak. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,457,177 and a net result of DKK 286,285 compared with DKK 1,120,314 the year before. Equity in the 2025 report amounted to DKK 2,306,048.